Efficacy and safety of Oral JAK inhibitor as a stabilizing treatment for active vitiligo JAAD
收藏Mendeley Data2026-04-09 收录
官方服务：
资源简介：
supplementary figures and supplementary tables
应用场景：
相关数据集
Efficacy and safety of compound glycyrrhizin in the patients with vitiligo: a systematic review and meta-analysis
Compound glycyrrhizin (CG) is widely used to treat vitiligo in China, and the efficacy and adverse events (AEs) of CG for vitiligo need further analysis. This study aimed to systematically reevaluate
DataCite Commons2023-06-22 更新100
Supplementary Material for: Upadacitinib was administered as a sequential salvage therapy for Acute Severe Ulcerative Colitis: A Case Report
Introduction: Acute Severe Ulcerative Colitis (ASUC) represents a medical emergency associated with high mortality and morbidity. While corticosteroids are the primary treatment, cases that are unresp
DataCite Commons2024-11-20 更新60
Comprehensive profiing of clinical JAK inhibitors in myeloproliferative neoplasms. Comprehensive profiing of clinical JAK inhibitors in myeloproliferative neoplasms
Comprehensive profiing of clinical JAK inhibitors in myeloproliferative neoplasms Overall design: HEL cells were treated in duplicate for 4 hour or 48 hours with DMSO control or 500nM of JAK inhibitor
NIAID Data Ecosystem40
Oral JAK Inhibitors in the Management of Nail Psoriasis: An Evidence Based Review
Nail psoriasis is a manifestation of psoriasis localized to the nails, often presenting with pitting, onycholysis, and subungual hyperkeratosis. Currently, there are no FDA approved treatments specifi
Mendeley Data70
Supplementary Figure S1. Switchers: SALT trajectories from baseline to end of JAK1 and JAK2.
Patient-level trajectories (gray lines) and group means (colored with 95% CIs) for switchers, stratified by reason for switching (insurance vs efficacy). Points represent baseline, end of 1stJAK inhib
NIAID Data Ecosystem50
